Latest Headlines

Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA
PR Newswire

PR Newswire

Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA

7 小时前

Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose
PR Newswire

PR Newswire

Haier Shines at Australian Open 2026: Official Partner Elevates the Game with Smart Innovation and Purpose

7 小时前

Les revendications de brevet soulevées par Tulip Innovation contre les batteries Sunwoda s'étendent à l'action de la Korea Trade Commission (Commission coréenne du commerce - KTC)
PR Newswire

PR Newswire

Les revendications de brevet soulevées par Tulip Innovation contre les batteries Sunwoda s'étendent à l'action de la Korea Trade Commission (Commission coréenne du commerce - KTC)

8 小时前

Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners
PR Newswire

PR Newswire

Life Time Miami Marathon & Half Delivers an Unforgettable Weekend for More Than 17,000 Runners

8 小时前

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
PR Newswire

PR Newswire

Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes

8 小时前

Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action
PR Newswire

PR Newswire

Tulip Innovation Patent Claims Against Sunwoda Batteries Expand to Include KTC Action

9 小时前

INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
PR Newswire

PR Newswire

INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics

9 小时前

Lee Kum Kee zahajuje ve spolupráci s UNESCO „Forever Flavors Project" s cílem vybudovat světový archiv kulinářských vzpomínek
PR Newswire

PR Newswire

Lee Kum Kee zahajuje ve spolupráci s UNESCO „Forever Flavors Project" s cílem vybudovat světový archiv kulinářských vzpomínek

9 小时前

Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)
PR Newswire

PR Newswire

Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 in Patients with Elevated Lp(a)

10 小时前

FDA Accepts LEQEMBI® IQLIKTM (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
PR Newswire

PR Newswire

FDA Accepts LEQEMBI® IQLIKTM (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review

10 小时前